ESMO Asia 2016: Cancer experts meet in Singapore from Dec. 16-19, 2016

November 08, 2016

LUGANO/SINGAPORE, 08 November 2016 - ESMO, the leading professional organisation for medical oncology, is pleased to announce the second ESMO Asia 2016 Congress, from 16 to 19 December at the Suntec Singapore Convention and Exhibition Centre. This scientific and educational congress is led by an international scientific committee and promotes the sharing of expertise and interaction between regional and international experts in oncology.

Late registration for ESMO Asia 2016 ends tomorrow, 9 November. Delegates can register here: http://www.esmo.org/Conferences/ESMO-Asia-2016-Congress/Registration

The Asia 2016 programme will offer state of the art science across all major tumour types. The scientific programme is already online here: http://www.esmo.org/Conferences/ESMO-Asia-2016-Congress/Programme

Delegates attending the ESMO Asia 2016 Congress will discuss current clinical challenges and novel treatment strategies for particular tumour subtypes as well as updates on translating emerging cancer therapeutics into clinical use.

As well as the latest science, Asia 2016 Congress will highlight bioethical, economic and social challenges posed by cancer such as the rising costs of treatments, the need for psychological support for patients, the need for better palliative care and the vital importance of improving access to innovative drugs.

Embargo information

Abstract accepted as Poster Discussion (suffix 'PD') and Poster (suffix 'P') will be online on Wednesday, 07 December 2016 at 16:00 hrs SGT (local Singapore Time).

Abstract accepted as Proffered Paper (suffix 'O') will be online on Wednesday, 14 December 2016 at 16:00 hrs SGT (local Singapore Time).

Late-breaking abstracts (prefix 'LBA') will be made public at the beginning of the official ESMO Asia 2016 Congress session during which they are presented.

Abstracts selected for official ESMO Press Programme (additional suffix '_PR') will be made public at 00:05 hrs SGT (local Singapore Time) on the day of presentation during the official ESMO Asia 2016 Congress programme.

With over 500 scheduled presentations and organised by a top international faculty, ESMO Asia 2016 Congress is the place to be for all medical and clinical oncologists, academic and community practising oncologists, clinical, basic, translational and industry researchers, young oncologists, radiotherapists, oncology surgeons, organ-based specialists and all other medical professionals involved in the prevention, diagnosis, treatment and follow-up of patients with different types of cancer.

Last year, ESMO Asia 2015 attracted 2965 oncology professionals from over 32 countries.

Media Registration

ESMO welcomes media interested in obtaining information and reporting on cancer issues. Registration to the ESMO Asia 2016 Congress is free to bona fide journalists on presentation of a letter of assignment and a valid press card.

To register as press, please fill out the media registration form here: http://esmo.formstack.com/forms/media_registration_form_esmoasia2016

We look forward to welcoming you in Singapore or to help you with any inquiry about remote coverage of ESMO Asia 2016.
-end-
The ESMO Press Office Team
media@esmo.og
Follow our news on @myESMO

European Society for Medical Oncology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.